THE CONTENT OF SERUM CYTOTOXINS UNDER LIVER CIRRHOSIS OF VIRAL ETIOLOGY AT VARIOUS STAGES OF COMPENSATION
- Authors: Kulikov V.E.1, Sharafutdinov M.G1, Khapman M.E1, Toneeva M.A1, Nikolaeva K.V1, Sapozhnikov A.N1, Proshina L.G2, Khoroshevskaya A.I2
-
Affiliations:
- The Ulyanovsk state university
- The Yaroslav the Wise Novgorod state university
- Issue: Vol 24, No 2 (2018)
- Pages: 83-86
- Section: Articles
- URL: https://journals.rcsi.science/0869-2106/article/view/38453
- DOI: https://doi.org/10.18821/0869-2106-2018-24-2-83-86
- ID: 38453
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
Vladimir Evgenievich Kulikov
The Ulyanovsk state university
Email: kulikov69@bk.ru
MD, Professor of the Department of Hospital Therapy of the Federal State Educational Establishment of Higher Education of the «Ulyanovsk State University» of the Ministry of Education and Science of the Russian Federation 432017, Ulyanovsk, Russian Federation
M. G Sharafutdinov
The Ulyanovsk state university432017, Ulyanovsk, Russian Federation
M. E Khapman
The Ulyanovsk state university432017, Ulyanovsk, Russian Federation
M. A Toneeva
The Ulyanovsk state university432017, Ulyanovsk, Russian Federation
K. V Nikolaeva
The Ulyanovsk state university432017, Ulyanovsk, Russian Federation
A. N Sapozhnikov
The Ulyanovsk state university432017, Ulyanovsk, Russian Federation
L. G Proshina
The Yaroslav the Wise Novgorod state university173003, Veliky Novgorod, Russian Federation
A. I Khoroshevskaya
The Yaroslav the Wise Novgorod state university173003, Veliky Novgorod, Russian Federation
References
- Назыров Ф.Г., Девятов А.В., Бабаджанов А.Х., Раимов С.А. Особенности развития и течения осложнений цирроза печени в зависимости от этиологического фактора. Новости хирургии. 2013; 21(4): 45-50.
- Голованова Е.В. Механизмы фиброзообразования при хронических заболеваниях печени и возможности антифибротической терапии. Consilium medicum. 2014; 16(8): 52-9.
- Ивашкин В.Т. Резистентный асцит у больных циррозами печени. М.: Медицина; 2013.
- Iwakir Y., Groszmann R.J. The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule. Hepatology. 2006; 43(2 Suppl. 1): S121-31.
- Giannitrapani L., Soresi М., Balasus D., Licata A., Montalto G. Genetic association of interleukin-6 polymorphism (-174 G/C) with chronic liver diseases and hepatocellular carcinoma. World J. Gastroenterol. 2013; 19(16): 2449-55.
- Osawa Y., Hoshi M., Yasuda I. Tumor necrosis factor-α promotes cholestasis-induced liver fibrosis in the mouse through tissue inhibitor of metalloproteinase-1 production in hepatic stellate cells. PloS One. 2013; 8(6): 65251-62.
- Handa P., Kowdley K.V. Chemokines: potent mediators of hepatic inflammation and fibrosis in chronic liver diseases. Ann. Hepatol. 2014; 13(1): 152-4.
- Филиппова Л.П., Белобородова Э.И., Белобородова Е.В., Алексеева А.С. Качество жизни больных циррозом печени в зависимости от тонуса вегетативной нервной системы. Бюллетень сибирской медицины. 2012; 11(4): 152-7.
- Яковенко Э.П., Яковенко А.В., Каграманова А.В. Современные подходы к терапии больных цирроз печени. Фарматека. 2012; (13): 88-93.
- Chen T.A., Sao C., Chen К., Lo G.H., Lin C.K., Yu H.C. et al. Effect of intravenous albumin on endotoxin removal, cytokines, and nitric oxide production in patients with cirrhosis and spontaneous bacterial peritonitis. Scand. J. Gastroenterol. 2009; 44(5): 619-25.
- Fuster D., Tsui J.I., Cheng D.M., Quinn E.K., Armah K.A., Nunes D. et al. Interleukin-6 is associated with noninvasive markers of liver fibrosis in HIV-infected patients with alcohol problems. AIDS Res. Hum. Retroviruses. 2013; 29(8): 1110-6.
- Мироджанов Г.К., Авезов С.А., Гиясов М.М., Абдуллаева З.М. Интерлейкин-6 и оксид азота в патогенезе портальной гипертензии и декомпенсации цирроза печени. Клиническая медицина. 2012; 90(1): 47-53.
- Li S., Huang X., Zhong H., Chen Z., Peng Q., Deng Y. et al. Tumour necrosis factor alpha (TNF-α) genetic polymorphisms and the risk of autoimmune liver disease: a meta-analysis. J. Genet. 2013; 92(3): 617-28.
- Lisman T., Porte R.J. Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences. Blood. 2010; 116(6): 878-85.